BCV
PFE icon

Banque Cantonale Vaudoise’s Pfizer PFE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.9K Buy
286,435
+139,113
+94% +$3.64M ﹤0.01% 241
2026
Q1 		$4.13M Sell
147,322
-55,005
-27% -$1.46M 0.16% 127
2025
Q4 		$5.04M Buy
202,327
+13,049
+7% +$329K 0.18% 105
2025
Q3 		$4.82M Sell
189,278
-92,252
-33% -$2.28M 0.18% 104
2025
Q2 		$6.83M Buy
281,530
+21,267
+8% +$496K 0.28% 72
2025
Q1 		$6.59M Buy
+260,263
New +$6.81M 0.29% 70
2024
Q3 		$11.2M Sell
385,284
-80,282
-17% -$2.34M 0.46% 37
2024
Q2 		$13M Sell
465,566
-4,145
-0.9% -$114K 0.52% 28
2024
Q1 		$13M Buy
469,711
+229,471
+96% +$6.37M 0.51% 33
2023
Q4 		$6.92M Sell
240,240
-114,228
-32% -$3.45M 0.3% 64
2023
Q3 		$11.8M Sell
354,468
-12,298
-3% -$435K 0.59% 28
2023
Q2 		$13.5M Buy
366,766
+37,221
+11% +$1.45M 0.63% 23
2023
Q1 		$13.4M Buy
329,545
+1,852
+0.6% +$80K 0.66% 21
2022
Q4 		$16.8M Buy
327,693
+38,119
+13% +$1.83M 0.88% 14
2022
Q3 		$12.7M Sell
289,574
-8,050
-3% -$391K 0.72% 18
2022
Q2 		$15.6M Sell
297,624
-41,188
-12% -$2.1M 0.81% 12
2022
Q1 		$17.5M Buy
338,812
+35,439
+12% +$1.84M 0.76% 16
2021
Q4 		$17.9M Sell
303,373
-50,506
-14% -$2.5M 0.7% 20
2021
Q3 		$15.2M Sell
353,879
-44,212
-11% -$1.96M 0.65% 20
2021
Q2 		$15.6M Buy
398,091
+30,034
+8% +$1.17M 0.69% 18
2021
Q1 		$13.3M Sell
368,057
-42,111
-10% -$1.5M 0.68% 22
2020
Q4 		$15.1M Sell
410,168
-28,732
-7% -$1.05M 0.84% 20
2020
Q3 		$15.3M Buy
438,900
+148,548
+51% +$5.21M 0.98% 17
2020
Q2 		$9.01M Sell
290,352
-42,228
-13% -$1.43M 0.66% 24
2020
Q1 		$10.3M Buy
332,580
+108,741
+49% +$3.71M 0.87% 22
2019
Q4 		$8.32M Buy
+223,839
New +$7.97M 0.57% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Banque Cantonale Vaudoise's PFE Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Pfizer (PFE) stake by 94% in Q2 2026, buying an estimated $3.64M and bringing the position to 286,435 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Banque Cantonale Vaudoise first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $17.9M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Banque Cantonale Vaudoise held 286,435 shares of Pfizer worth $6.9K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 139,113 Pfizer shares in Q2 2026, an estimated $3.64M.
  • Pfizer made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #241 holding.
  • Banque Cantonale Vaudoise first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Pfizer position peaked at $17.9M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.